Homo sapiens Protein: TECPR2 | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||
InnateDB Protein | IDBP-21134.6 | ||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||
Gene Symbol | TECPR2 | ||||||||||||||||||
Protein Name | tectonin beta-propeller repeat containing 2 | ||||||||||||||||||
Synonyms | KIAA0329; SPG49; | ||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||
Ensembl Protein | ENSP00000352510 | ||||||||||||||||||
InnateDB Gene | IDBG-21132 (TECPR2) | ||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||
UniProt Annotation | |||||||||||||||||||
Function | Probably plays a role as positive regulator of autophagy. {ECO:0000269PubMed:23176824}. | ||||||||||||||||||
Subcellular Localization | |||||||||||||||||||
Disease Associations | Spastic paraplegia 49, autosomal recessive (SPG49) [MIM:615031]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. Complicated forms are recognized by additional variable features including spastic quadriparesis, seizures, dementia, amyotrophy, extrapyramidal disturbance, cerebral or cerebellar atrophy, optic atrophy, and peripheral neuropathy, as well as by extra neurological manifestations. SPG49 is characterized by delayed psychomotor development, mental retardation, and onset of spastic paraplegia in the first decade. Affected individuals also have dysmorphic features, thin corpus callosum on brain imaging, and episodes of central apnea, which may be fatal. {ECO:0000269PubMed:23176824}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||
Tissue Specificity | Detected in skin fibroblast (at protein level). {ECO:0000269PubMed:23176824}. | ||||||||||||||||||
Comments | |||||||||||||||||||
Interactions | |||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 2 experimentally validated interaction(s) in this database.
|
||||||||||||||||||
Gene Ontology | |||||||||||||||||||
Molecular Function |
|
||||||||||||||||||
Biological Process |
|
||||||||||||||||||
Cellular Component |
|
||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||
PDB ID | |||||||||||||||||||
InterPro |
IPR001680
WD40 repeat IPR006624 Beta-propeller repeat TECPR IPR009091 Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II IPR017986 WD40-repeat-containing domain |
||||||||||||||||||
PFAM |
PF00400
PF06462 |
||||||||||||||||||
PRINTS | |||||||||||||||||||
PIRSF | |||||||||||||||||||
SMART |
SM00320
SM00706 |
||||||||||||||||||
TIGRFAMs | |||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||
Modification | |||||||||||||||||||
Cross-References | |||||||||||||||||||
SwissProt | O15040 | ||||||||||||||||||
PhosphoSite | PhosphoSite-O15040 | ||||||||||||||||||
TrEMBL | |||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||
Entrez Gene | 9895 | ||||||||||||||||||
UniGene | Hs.195667 | ||||||||||||||||||
RefSeq | NP_055659 | ||||||||||||||||||
HUGO | HGNC:19957 | ||||||||||||||||||
OMIM | 615000 | ||||||||||||||||||
CCDS | CCDS32162 | ||||||||||||||||||
HPRD | 17184 | ||||||||||||||||||
IMGT | |||||||||||||||||||
EMBL | AB002295 AB002327 AL136293 AL137229 BC136647 BC142667 BC142715 BC151230 CH471061 | ||||||||||||||||||
GenPept | AAI36648 AAI42668 AAI42716 AAI51231 BAA20757 BAA20787 EAW81789 | ||||||||||||||||||